{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-124162","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2025-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.747975+00:00","generated_at":"2026-05-16T12:27:23.233091+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PMGC subsidiaries advance drug discovery program and achieve AS9100 certification","bullets":["NorthStrive Biosciences advances to Phase III of AI drug discovery program with YuvaBio, targeting muscle preservation via mitochondrial function.","Phase III will generate biological data on AI-selected compounds, including cytotoxicity screening and ANT1 expression testing over 6-9 weeks.","AGA Precision Systems achieves AS9100 certification, the globally recognized quality standard for aerospace, defense, and space industries.","AGA is evaluating humanoid robotics integration for advanced manufacturing; no assurance of implementation or benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-124162","json":"https://secwatch.observer/filing/0001213900-25-124162.json","markdown":"https://secwatch.observer/filing/0001213900-25-124162.md","text":"https://secwatch.observer/filing/0001213900-25-124162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390025124162/0001213900-25-124162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390025124162/ea0270503-8k_pmgchold.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:27:23.233091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}